Drug Type Aptamers |
Synonyms- |
Target |
Action inhibitors, antagonists |
Mechanism PDGFB inhibitors(Platelet-derived growth factor subunit B inhibitors), VEGFR antagonists(Vascular endothelial growth factor receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dystrophy, Macular | Preclinical | United States | 13 Aug 2014 |